|
⚲
|
| Keyboard |
| HBM BioVentures Cayman Ltd
✚
|
|
|---|---|
| CIK # | 0001232258 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001232258] | |
| 4 | [0001232258] | |
| SC 13D | [0001232258] | |
| SC 13G | [0001232258] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Mineralys Therapeutics Inc MLYS
Common Stock
|
2023-02-14 | Buy | 312,500 | $16.00 | 5,000,000 |
|
Mineralys Therapeutics Inc MLYS
Series A Preferred Stock · derivative
|
2023-02-14 | Conversion | 20,962,895 | $0.00 | |
|
Mineralys Therapeutics Inc MLYS
Series B Preferred Stock · derivative
|
2023-02-14 | Conversion | 10,411,846 | $0.00 | |
|
Mineralys Therapeutics Inc MLYS
Common Stock
|
2023-02-14 | Conversion | 964,238 | ||
|
Mineralys Therapeutics Inc MLYS
Common Stock
|
2023-02-14 | Conversion | 1,941,368 | ||
|
IO Biotech Inc IOBT
Common Stock
|
2021-11-09 | Conversion | 2,365,545 | ||
|
IO Biotech Inc IOBT
Common Stock
|
2021-11-09 | Buy | 325,000 | $14.00 | 4,550,000 |
|
IO Biotech Inc IOBT
Series C Preferred Stock · derivative
|
2021-11-09 | Conversion | 188,168 | $0.00 | |
|
Werewolf Therapeutics Inc HOWL
Common Stock
|
2021-05-04 | Conversion | 625,995 | ||
|
Werewolf Therapeutics Inc HOWL
Series B Preferred Stock · derivative
|
2021-05-04 | Conversion | 5,426,819 | $0.00 | |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-09-14 | Sell | 3,429 | $8.52 | 29,215 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-09-13 | Sell | 22,721 | $8.54 | 194,037 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-09-12 | Sell | 10,458 | $8.63 | 90,253 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-08-31 | Sell | 639 | $9.50 | 6,070 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-08-08 | Sell | 2,013 | $10.50 | 21,136 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-08-07 | Sell | 17,790 | $10.50 | 186,795 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-07-28 | Sell | 6,585 | $10.51 | 69,208 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-07-24 | Sell | 160 | $10.50 | 1,680 |
|
Nabriva Therapeutics Legacy PLC NBRV
Ordinary Shares
|
2017-07-20 | Sell | 23,445 | $10.50 | 246,172 |
|
Nabriva Therapeutics AG NBRV
Ordinary Shares
|
2017-07-20 | Sell | 23,445 | $10.50 | 246,172 |
| showing 20 of 77 most recent transactions | |||||